(Q35553375)

English

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement

scientific article published on October 2004

Statements

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement (English)
1 October 2004
1218-1221

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit